StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)

Close on Nov 20, 2026Market cap $1.92BP/E –Yield –

NeoGenomics net income

Net income is the profit left for shareholders after every expense, interest and tax.

NeoGenomics's net income for the twelve months ending Sep 30, 2026 was -$32.30M. For fiscal 2025 it was -$108.03M. The highest annual figure on record is $8.01M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$108.03M–
FY2024Dec 31, 2024-$78.73M–
FY2023Dec 31, 2023-$87.97M–
FY2022Dec 31, 2022-$144.25M–
FY2021Dec 31, 2021-$8.35M-300.1%
FY2020Dec 31, 2020$4.17M-47.9%
FY2019Dec 31, 2019$8.01M+203.3%
FY2018Dec 31, 2018$2.64M–
FY2017Dec 31, 2017-$396.00K–
FY2016Dec 31, 2016-$6.14M–
FY2015Dec 31, 2015-$2.54M-323.9%
FY2014Dec 31, 2014$1.13M-44.3%
FY2013Dec 31, 2013$2.03M+3027.7%
FY2012Dec 31, 2012$65.00K–
FY2011Dec 31, 2011-$1.18M–
FY2010Dec 31, 2010-$3.30M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$7.55M–
Q2 FY2026Jun 30, 2026$2.24M–
Q1 FY2026Mar 31, 2026-$17.11M–
Q4 FY2025Dec 31, 2025-$9.88M–
Q3 FY2025Sep 30, 2025-$27.13M–
Q2 FY2025Jun 30, 2025-$45.09M–
Q1 FY2025Mar 31, 2025-$25.92M–
Q4 FY2024Dec 31, 2024-$15.32M–
Q3 FY2024Sep 30, 2024-$17.70M–
Q2 FY2024Jun 30, 2024-$18.64M–
Q1 FY2024Mar 31, 2024-$27.06M–
Q4 FY2023Dec 31, 2023-$14.33M–
Q3 FY2023Sep 30, 2023-$18.52M–
Q2 FY2023Jun 30, 2023-$24.33M–
Q1 FY2023Mar 31, 2023-$30.80M–
Q4 FY2022Dec 31, 2022-$22.69M–
Q3 FY2022Sep 30, 2022-$36.85M–
Q2 FY2022Jun 30, 2022-$35.30M-146.5%
Q1 FY2022Mar 31, 2022-$49.41M–
Q4 FY2021Dec 31, 2021-$41.76M-370.9%
Q3 FY2021Sep 30, 2021-$20.35M-895.8%
Q2 FY2021Jun 30, 2021$75.87M–
Q1 FY2021Mar 31, 2021-$22.11M–
Q4 FY2020Dec 31, 2020$15.42M+144.9%
Q3 FY2020Sep 30, 2020$2.56M+19.3%
Q2 FY2020Jun 30, 2020-$6.82M-442.7%
Q1 FY2020Mar 31, 2020-$6.98M–
Q4 FY2019Dec 31, 2019$6.30M+1683.6%
Q3 FY2019Sep 30, 2019$2.14M+5.9%
Q2 FY2019Jun 30, 2019$1.99M–
Q1 FY2019Mar 31, 2019-$2.42M-476.4%
Q4 FY2018Dec 31, 2018$353.00K-92.2%
Q3 FY2018Sep 30, 2018$2.02M–
Q2 FY2018Jun 30, 2018-$380.00K-178.7%
Q1 FY2018Mar 31, 2018$644.00K–
Q4 FY2017Dec 31, 2017$4.55M–
Q3 FY2017Sep 30, 2017-$4.26M–
Q2 FY2017Jun 30, 2017$483.00K–
Q1 FY2017Mar 31, 2017-$1.17M–
Q4 FY2016Dec 31, 2016-$6.22M–

More NeoGenomics figures

See a number that looks wrong?